Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chiron -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (1327)	12/8/2004 10:46:25 AM
From: fred hayes	Read Replies (2) \| Respond to of 1352

George: Ya, I hadn't seen that report. Certainly sounds pessimistic. But I can't believe that the problems won't be resolved for next season. I was thinking it was a 90 percent chance for resolution, but after reading the Piper take I may be way too optimistic. But CHIR only paid $900 million for that plant, and maybe has something over a $ billion invested in it. I just can't see how the problem could be worth $2.5 billion unless it was clear that the vaccine business is down the tube, and even then I wonder if it would be worth $2.5 billion. Place your bets, take your chances... fred